دورية أكاديمية
Ventriculo-peritoneal shunting is a safe and effective treatment for idiopathic intracranial hypertension.
العنوان: | Ventriculo-peritoneal shunting is a safe and effective treatment for idiopathic intracranial hypertension. |
---|---|
المؤلفون: | Bjornson, Anna, Tapply, Ian, Nabbanja, Eva, Lalou, Afrodite-Despina, Czosnyka, Marek, Czosnyka, Zofia, Muthusamy, Brinda, Garnett, Matthew |
بيانات النشر: | Informa UK Limited //dx.doi.org/10.1080/02688697.2018.1538478 Br J Neurosurg |
سنة النشر: | 2019 |
المجموعة: | Apollo - University of Cambridge Repository |
مصطلحات موضوعية: | Idiopathic intracranial hypertension, Orbis sigma valve, Ventriculo-peritoneal shunt, Adolescent, Adult, Child, Databases, Factual, Female, Headache Disorders, Humans, Male, Middle Aged, Postoperative Care, Postoperative Complications, Pseudotumor Cerebri, Reoperation, Retrospective Studies, Spinal Puncture, Treatment Outcome, Ventriculoperitoneal Shunt, Vision Disorders, Visual Acuity, Young Adult |
الوصف: | PURPOSE: To determine the outcome of ventriculo-peritoneal shunts as a treatment for idiopathic intracranial hypertension (IIH) Materials and Methods: Retrospective case series of 28 patients with IIH and evidence of raised intracranial pressure (ICP) who underwent shunt insertion. Patients were identified from a prospectively updated operative database. A case-notes review was performed and data on type of shunt, pre- and post-operative symptoms, ophthalmological findings and post-operative complications were recorded. RESULTS: All patients had symptoms of IIH that had failed medical management. Twelve patients had previous lumbo-peritoneal shunts and 2 patients had previous venous sinus stents. All patients had evidence of raised ICP as papilloedema and raised CSF pressure on lumbar puncture. Twenty-seven patients received a ventriculo-peritoneal shunt and 1 patient a ventriculo-atrial shunt. Twenty-six patients received Orbis Sigma Valves and 2 patients Strata valves. At follow-up all patients (100%) had improvement/resolution of papilloedema, 93% had improved visual acuity and 84% had improved headaches. Mean time to last follow-up was 15 (range 4-96) months. Complications occurred in 3 patients (11%): 2 patients required revision of their peritoneal catheters and 1 patient had an anti-siphon device inserted. CONCLUSIONS: Previous literature reported a ventricular shunt revision rate of 22-42% in the management of IIH. We demonstrate ventriculo-peritoneal shunts to be an effective treatment with a revision rate of 11% compared to the previously reported 22-42%. |
نوع الوثيقة: | article in journal/newspaper |
وصف الملف: | Print-Electronic; application/vnd.openxmlformats-officedocument.wordprocessingml.document |
اللغة: | English |
العلاقة: | https://www.repository.cam.ac.uk/handle/1810/290489Test |
DOI: | 10.17863/CAM.37716 |
الإتاحة: | https://doi.org/10.17863/CAM.37716Test https://www.repository.cam.ac.uk/handle/1810/290489Test |
رقم الانضمام: | edsbas.AB7992CD |
قاعدة البيانات: | BASE |
DOI: | 10.17863/CAM.37716 |
---|